pravastatin has been researched along with Infarction, Middle Cerebral Artery in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beretta, S; Cai, R; Carone, D; Cattalini, A; Conti, E; Cuccione, E; de Curtis, M; Ferrarese, C; Librizzi, L; Monza, L; Sala, G; Versace, A | 1 |
| Ambrosini, MV; Mariucci, G; Spaccatini, C; Taha, E; Tantucci, M; Tozzi, A | 1 |
| Hori, M; Kitagawa, K; Ohyama, N; Sasaki, T; Sugiura, S; Terasaki, Y; Todo, K; Yagita, Y | 1 |
| Berger, C; Maurer, MH; Schwab, S; Xia, F | 1 |
1 review(s) available for pravastatin and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Neuroprotection by pravastatin in acute ischemic stroke in rats.
Topics: Animals; Anticholesteremic Agents; Brain Ischemia; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Pravastatin; Rats; Rats, Wistar; Stroke; Treatment Outcome | 2008 |
3 other study(ies) available for pravastatin and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Capillary Permeability; Guinea Pigs; Infarction, Middle Cerebral Artery; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase 3; Neuroprotective Agents; Pravastatin; Proto-Oncogene Proteins c-akt; Time Factors; Zonula Occludens-1 Protein | 2015 |
Intravenous administration of pravastatin immediately after middle cerebral artery occlusion reduces cerebral oedema in spontaneously hypertensive rats.
Topics: Animals; Anticholesteremic Agents; Apoptosis; Astrocytes; Brain Edema; Enzyme Induction; Infarction, Middle Cerebral Artery; Injections, Intravenous; Male; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Inbred SHR | 2011 |
Postischemic administration of HMG CoA reductase inhibitor inhibits infarct expansion after transient middle cerebral artery occlusion.
Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Male; Pravastatin; Rats; Rats, Wistar | 2007 |